| Ident. | Authors (with country if any) | Title |
|---|
| 000381 (2016) |
Eric N. Beck [Canada] ; Quincy J. Almeida | Dopa-Responsive Balance Changes Depend on Use of Internal Versus External Attentional Focus in Parkinson Disease. |
| 000395 (2016) |
Abdul Qayyum Rana ; Mohamad Saleh ; Muhammad Saad Yousuf ; Wasim Mansoor ; Syed Hussaini ; Maniza Rahman ; Zohair Iqbal | DOPA-sparing strategy in the treatment of young onset Parkinson's disease |
| 000522 (2015) |
Tom M. Johnston [Canada] ; Susan H. Fox | Symptomatic Models of Parkinson's Disease and L-DOPA-Induced Dyskinesia in Non-human Primates. |
| 000536 (2015) |
Philippe Huot [Canada] ; William D. Hutchison [Canada] | Serotonin/dopamine transporter ratio as a predictor of L-dopa-induced dyskinesia. |
| 000592 (2015) |
Matthieu F. Bastide [France] ; Wassilios G. Meissner [France] ; Barbara Picconi [Italie] ; Stefania Fasano [Italie] ; Pierre-Olivier Fernagut [France] ; Michael Feyder [Suède] ; Veronica Francardo [Suède] ; Cristina Alcacer [Suède] ; Yunmin Ding [États-Unis] ; Riccardo Brambilla [Italie] ; Gilberto Fisone [Suède] ; A. Jon Stoessl [Canada] ; Mathieu Bourdenx [France] ; Michel Engeln [France] ; Sylvia Navailles [France] ; Philippe De Deurwaerdère [France] ; Wai Kin D. Ko [France] ; Nicola Simola [Italie] ; Micaela Morelli [Italie] ; Laurent Groc [France] ; Maria-Cruz Rodriguez [Espagne] ; Eugenia V. Gurevich [États-Unis] ; Maryka Quik [États-Unis] ; Michele Morari [Italie] ; Manuela Mellone [Italie] ; Fabrizio Gardoni [Italie] ; Elisabetta Tronci [Italie] ; Dominique Guehl [France] ; François Tison [France] ; Alan R. Crossman [Royaume-Uni] ; Un Jung Kang [Suède] ; Kathy Steece-Collier [États-Unis] ; Susan Fox [Canada] ; Manolo Carta [Italie] ; M. Angela Cenci [Suède] ; Erwan Bézard [Royaume-Uni] | Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease. |
| 000595 (2015) |
Yoshiaki Furukawa [Japon] ; Stephen J. Kish [Canada] | Parkinsonism in GTP cyclohydrolase 1-deficient DOPA-responsive dystonia. |
| 000828 (2015) |
Kaylena A. Ehgoetz Martens [Canada] ; Colin G. Ellard [Canada] ; Quincy J. Almeida [Canada] | Anxiety-provoked gait changes are selectively dopa-responsive in Parkinson's disease. |
| 000877 (2014) |
Philippe Huot [Canada] ; Tom H. Johnston [Canada] ; Katie D. Lewis [Australie] ; James B. Koprich [Canada] ; M Gabriela Reyes [Canada] ; Susan H. Fox [Canada] ; Matthew J. Piggott [Australie] ; Jonathan M. Brotchie [Canada] | UWA-121, a mixed dopamine and serotonin re-uptake inhibitor, enhances L-DOPA anti-parkinsonian action without worsening dyskinesia or psychosis-like behaviours in the MPTP-lesioned common marmoset. |
| 000A35 (2014) |
St Masoud [Canada] ; Lm Vecchio [Canada] ; Y. Bergeron ; Mm Hossain [États-Unis] ; Lt Nguyen [Canada] ; Mk Bermejo [Canada] ; B. Kile [États-Unis] ; Td Sotnikova [Italie, Russie] ; Wb Siesser [États-Unis] ; Rr Gainetdinov [Italie, Russie] ; Rm Wightman [États-Unis] ; Mg Caron [États-Unis] ; Jr Richardson [États-Unis] ; Gw Miller [États-Unis] ; Aj Ramsey [Canada] ; M. Cyr ; A. Salahpour [Canada] | Increased expression of the dopamine transporter leads to loss of dopamine neurons, oxidative stress and L-DOPA reversible motor deficits |
| 000A67 (2014) |
James K. R. Stevenson [Canada] ; Chonho Lee [Singapour] ; Bu-Sung Lee [Singapour] ; Pouria Talebifard [Canada] ; Edna Ty [Canada] ; Kristina Aseeva [Canada] ; Meeko M. K. Oishi [États-Unis] ; Martin J. Mckeown [Canada] | Excessive Sensitivity to Uncertain Visual Input in L-DOPA-Induced Dyskinesias in Parkinson’s Disease: Further Implications for Cerebellar Involvement |
| 000B60 (2014) |
Thérèse Di Paolo [Canada] ; Laurent Grégoire [Canada] ; Dominik Feuerbach [Canada] ; Walid Elbast [Canada] ; Markus Weiss [Canada] ; Baltazar Gomez-Mancilla [Canada] | AQW051, a novel and selective nicotinic acetylcholine receptor α7 partial agonist, reduces l-Dopa-induced dyskinesias and extends the duration of l-Dopa effects in parkinsonian monkeys. |
| 000C43 (2013) |
Philippe Huot [Canada] ; Tom H. Johnston ; James B. Koprich ; Susan H. Fox ; Jonathan M. Brotchie | The pharmacology of L-DOPA-induced dyskinesia in Parkinson's disease. |
| 000C50 (2013) |
James B. Koprich [Canada] ; Philippe Huot ; Susan H. Fox ; Keith Jarvie ; Anthony E. Lang ; Philip Seeman ; Jonathan M. Brotchie | The effects of fast-off-D2 receptor antagonism on L-DOPA-induced dyskinesia and psychosis in parkinsonian macaques. |
| 000D42 (2013) |
Nicolas Morin [Canada] ; Laurent Grégoire ; Marc Morissette ; Sandrine Desrayaud ; Baltazar Gomez-Mancilla ; Fabrizio Gasparini ; Thérèse Di Paolo | MPEP, an mGlu5 receptor antagonist, reduces the development of L-DOPA-induced motor complications in de novo parkinsonian monkeys: biochemical correlates. |
| 000E29 (2013) |
Nicolas Morin [Canada] ; Marc Morissette ; Laurent Grégoire ; Baltazar Gomez-Mancilla ; Fabrizio Gasparini ; Thérèse Di Paolo | Chronic treatment with MPEP, an mGlu5 receptor antagonist, normalizes basal ganglia glutamate neurotransmission in L-DOPA-treated parkinsonian monkeys. |
| 000E37 (2013) |
Golnasim Riahi ; Marc Morissette ; Pershia Samadi ; Martin Parent ; Thérèse Di Paolo | Basal ganglia serotonin 1B receptors in parkinsonian monkeys with L-DOPA-induced dyskinesia. |
| 001038 (2013) |
James B. Koprich [Canada] ; Philippe Huot [Canada] ; Susan H. Fox [Canada] ; Keith Jarvie [Canada] ; Anthony E. Lang [Canada] ; Philip Seeman [Canada] ; Jonathan M. Brotchie [Canada] | The effects of fast-off-D2 receptor antagonism on L-DOPA-induced dyskinesia and psychosis in parkinsonian macaques |
| 001083 (2013) |
Christopher Kobylecki [Royaume-Uni] ; Alan R. Crossman [Royaume-Uni] ; Paula Ravenscroft [Royaume-Uni, Canada] | Alternative splicing of AMPA receptor subunits in the 6-OHDA-lesioned rat model of Parkinson's disease and L-DOPA-induced dyskinesia |
| 001101 (2012) |
Francesca Manag [Italie] ; Stefano Espinoza [Italie] ; Ali Salahpour [Canada] ; Tatyana D. Sotnikova [Italie] ; Marc G. Caron [États-Unis] ; Richard T. Premont [États-Unis] ; Raul R. Gainetdinov [Italie, États-Unis] | The role of GRK6 in animal models of Parkinson's Disease and L-DOPA treatment |
| 001191 (2012) |
Philippe Huot [Canada] ; Tom H. Johnston ; James B. Koprich ; Ahmed Aman ; Susan H. Fox ; Jonathan M. Brotchie | L-745,870 reduces L-DOPA-induced dyskinesia in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's disease. |
| 001293 (2012) |
Tom H. Johnston [Canada] ; Zak Millar ; Philippe Huot ; Keith Wagg ; Sherri Thiele ; Danielle Salomonczyk ; Christopher J. Yong-Kee ; Michael N. Gandy ; Matthew Mcildowie ; Katie D. Lewis ; Jordi Gomez-Ramirez ; Joohyung Lee ; Susan H. Fox ; Mathew Martin-Iverson ; Joanne E. Nash ; Matthew J. Piggott ; Jonathan M. Brotchie | A novel MDMA analogue, UWA-101, that lacks psychoactivity and cytotoxicity, enhances L-DOPA benefit in parkinsonian primates. |
